Sign In  |  Register  |  About San Anselmo  |  Contact Us

San Anselmo, CA
September 01, 2020 1:33pm
7-Day Forecast | Traffic
  • Search Hotels in San Anselmo

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Company Update: Biogen Idec Inc (NASDAQ:BIIB) – Results from B-YOND Extension Study Reinforce Long-Term Clinical Profile of ALPROLIX for the Treatment of Hemophilia B

[Business Wire] – DALLAS–(BUSINESSWIRE)– New clinical data support the long-term safety and efficacy of ALPROLIX® [Coagulation Factor IX (Recombinant), Fc Fusion Protein] in people with severe hemophilia B treated for up to two . . . → Read More: Company Update: Biogen Idec Inc (NASDAQ:BIIB) – Results from B-YOND Extension Study Reinforce Long-Term Clinical Profile of ALPROLIX for the Treatment of Hemophilia B Similar Articles: Company Update: Biogen Idec Inc (NASDAQ:BIIB) – Biogen 2015 Annual Shareholder Meeting Webcast Stock Update: Biogen Idec Inc (NASDAQ:BIIB) – Biogen Inc. (Nasdaq: BIIB) to Ring The Nasdaq Stock Market Opening Bell Stock Update: Biogen Idec Inc (NASDAQ:BIIB) – Biogen Presents New Anti-LINGO-1 Phase 2 Acute Optic Neuritis Data Demonstrating Neurological Repair
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 SanAnselmo.com & California Media Partners, LLC. All rights reserved.